Moreover, incorporating alternative treatment modalities, such as radiotherapy, into combination regimens, as demonstrated in oral squamous carcinoma and BRCA1-deficient breast cancer [151, 152], may enhance the efficacy of acquired vulnerability-based approaches. The gene discussed is BRCA1; the disease is breast cancer.